Literature DB >> 15308707

Conformation- and fusion-defective mutations in the hypothetical phospholipid-binding and fusion peptides of viral hemorrhagic septicemia salmonid rhabdovirus protein G.

A Rocha1, S Ruiz, C Tafalla, J M Coll.   

Abstract

Fourteen single and two double point mutants in the highly conserved region (positions 56 to 159) of the G gene of viral hemorrhagic septicaemia virus (VHSV), a salmonid rhabdovirus, were selected and obtained in plasmids by site-directed mutagenesis. Fish cell monolayers transfected with the mutant plasmids were then assayed for protein G (pG) expression, conformation-dependent monoclonal antibody (MAb) reactivity, and cell-cell fusion. Some mutations located in the phospholipid-binding p2 peptide (positions 82 to 110; mutants P86A, A96E, G98A, and R107A) abolished both MAb recognition and fusion activity, while others (P79A, L85S, and R103A) abolished MAb recognition but retained fusion at similar or lower pHs compared to those for the wild type. Phospholipid-binding assays of p2-derived synthetic peptides suggested that phosphatidylserine binding was not affected by the mutations studied. On the other hand, three (P79A, L85S, and T135E) of the four mutants retaining fusion activity mapped around two locations showing amino acid variation in 22 VHSV isolates and in neutralizing MAb-resistant mutants described previously. Mutations located in the hypothetical fusion peptide (positions 142 to 159; mutants F147K, P148K, and W154K) abolished both MAb recognition and fusion activity. The existence of mutants with altered conformation and defective fusion in both p2 and fusion peptides provides further evidence in favor of the participation of these and adjacent regions in some of the steps of the VHSV fusion processes, as suggested by previous studies. In addition, because the studied region induced strong immunological responses in trout, some of the mutants described here might be used to design attenuated VHSV vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308707      PMCID: PMC506951          DOI: 10.1128/JVI.78.17.9115-9122.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Low pH-induced conformational changes in vesicular stomatitis virus glycoprotein involve dramatic structure reorganization.

Authors:  F A Carneiro; A S Ferradosa; A T Da Poian
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

2.  Improvement of transfection efficiency of epithelioma papulosum cyprini carp cells by modification of cell cycle and use of an optimal promoter.

Authors:  A Rocha; S Ruiz; J M Coll
Journal:  Mar Biotechnol (NY)       Date:  2004-11-04       Impact factor: 3.619

3.  DNA vaccination by immersion and ultrasound to trout viral haemorrhagic septicaemia virus.

Authors:  M Fernandez-Alonso; A Rocha; J M Coll
Journal:  Vaccine       Date:  2001-04-30       Impact factor: 3.641

4.  Experimental susceptibility of turbot Scophthalmus maximus to viral haemorrhagic septicaemia virus isolated from cultivated turbot.

Authors:  M Snow; D A Smail
Journal:  Dis Aquat Organ       Date:  1999-11-30       Impact factor: 1.802

5.  Rescue of synthetic salmonid rhabdovirus minigenomes.

Authors:  Stéphane Biacchesi; Yan-Xing Yu; Monique Béarzotti; Carolina Tafalla; Miriam Fernandez-Alonso; Michel Brémont
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

6.  Deduced structural model for animal rhabdovirus glycoproteins.

Authors:  P J Walker; K Kongsuwan
Journal:  J Gen Virol       Date:  1999-05       Impact factor: 3.891

7.  Mutations in the glycoprotein of viral haemorrhagic septicaemia virus that affect virulence for fish and the pH threshold for membrane fusion.

Authors:  Y Gaudin; P de Kinkelin; A Benmansour
Journal:  J Gen Virol       Date:  1999-05       Impact factor: 3.891

8.  A protein G fragment from the salmonid viral hemorrhagic septicemia rhabdovirus induces cell-to-cell fusion and membrane phosphatidylserine translocation at low pH.

Authors:  A M Estepa; A I Rocha; V Mas; L Pérez; J A Encinar; E Nuñez; A Fernandez; J M Gonzalez Ros; F Gavilanes; J M Coll
Journal:  J Biol Chem       Date:  2001-10-04       Impact factor: 5.157

9.  DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish.

Authors:  C H Kim; M C Johnson; J D Drennan; B E Simon; E Thomann; J A Leong
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

10.  Recovery of NV knockout infectious hematopoietic necrosis virus expressing foreign genes.

Authors:  S Biacchesi; M I Thoulouze; M Béarzotti; Y X Yu; M Brémont
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

View more
  5 in total

Review 1.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

2.  Internalization and fusion mechanism of vesicular stomatitis virus and related rhabdoviruses.

Authors:  Xiangjie Sun; Shoshannah L Roth; Michele A Bialecki; Gary R Whittaker
Journal:  Future Virol       Date:  2010       Impact factor: 1.831

3.  Antibody recognition of the glycoprotein g of viral haemorrhagic septicemia virus (VHSV) purified in large amounts from insect larvae.

Authors:  Paloma Encinas; Silvia Gomez-Sebastian; Maria Carmen Nunez; Eduardo Gomez-Casado; Jose M Escribano; Amparo Estepa; Julio Coll
Journal:  BMC Res Notes       Date:  2011-06-21

4.  Molecular and cellular aspects of rhabdovirus entry.

Authors:  Aurélie A V Albertini; Eduard Baquero; Anna Ferlin; Yves Gaudin
Journal:  Viruses       Date:  2012-01-18       Impact factor: 5.048

5.  Reverse transcription loop-mediated isothermal amplification (RT-LAMP) for rapid detection of viral hemorrhagic septicaemia virus (VHS).

Authors:  H Soliman; M El-Matbouli
Journal:  Vet Microbiol       Date:  2005-12-27       Impact factor: 3.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.